Advisory Services Network’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-58
Closed -$356 2801
2026
Q1
$356 Buy
+58
New +$482 ﹤0.01% 4481
2025
Q4
Sell
-58
Closed -$846 2439
2025
Q3
$846 Buy
+58
New +$694 ﹤0.01% 3964
2024
Q1
Sell
-93
Closed -$6.28K 1999
2023
Q4
$6.28K Buy
+93
New +$5.7K ﹤0.01% 3029
2023
Q2
Sell
-63
Closed -$3.33K 1998
2023
Q1
$3.33K Hold
63
﹤0.01% 3287
2022
Q4
$4.22K Buy
+63
New +$5.79K ﹤0.01% 3184

Other funds holding DNA

Advisory Services Network's DNA Position: Q2 2026 in Review

Advisory Services Network sold out of Ginkgo Bioworks (DNA) in Q2 2026, closing a stake of 58 shares — an estimated $356 sold.

Advisory Services Network first reported a position in DNA in Q4 2022 and held it in 5 quarters. The position peaked at $6.28K in Q4 2023. 184 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Advisory Services Network reported no remaining Ginkgo Bioworks position as of Q2 2026 after selling out during the quarter.
  • Advisory Services Network sold 58 Ginkgo Bioworks shares in Q2 2026, an estimated $356.
  • Advisory Services Network first reported a position in Ginkgo Bioworks in Q4 2022 and held it in 5 quarters.
  • Advisory Services Network's Ginkgo Bioworks position peaked at $6.28K in Q4 2023.
  • 184 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.